![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Publisher: Adis International
ISSN: 1173-5503
Source: PharmacoEconomics and Outcomes News, Vol.1, Iss.468, 2004-01, pp. : 3-3
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Tegaserod improves QOL, cost effective in IBS
Inpharma, Vol. 1, Iss. 1468, 2004-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 308, 2001-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Pimecrolimus cost effective, improves QOL in paediatric atopic dermatitis
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 379, 2002-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Tiotropium bromide improves outcomes, QOL at acceptable cost
Inpharma, Vol. 1, Iss. 1426, 2004-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Tiotropium bromide improves outcomes, QOL at acceptable cost
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 447, 2004-01 ,pp. :